Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder

BJU International

Volumn 108, Issue 8 B, 2011, Pages

  May, Matthias ^a   Bastian, Patrick J ^b   Burger, Maximilian ^c   Bolenz, Christian ^d   Trojan, Lutz ^d   Herrmann, Edwin ^e   Wülfing, Christian ^e   Müller, Stefan C ^f   Ellinger, Jörg ^f   Buchner, Alexander ^b   Stief, Christian G ^b   Tilki, Derya ^b   Otto, Wolfgang ^c   Höfner, Thomas ^d   Hohenfellner, Markus ^d   Haferkamp, Axel ^g   Roigas, Jan ^h   Zacharias, Mario ⁱ   Wieland, Wolf F ^c   Fritsche, Hans Martin ^c  

^a Urologische Klinik   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f UNIVERSITY OF BONN   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

ⁱ Vivantes Klinikum AVK Berlin   (Germany)

Author keywords

bladder cancer; pT0 stage; radical cystectomy; urothelial carcinoma

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UROTHELIAL CARCINOMA OF THE URINARY BLADDER;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 80054019470     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10189.x     Document Type: Article

References (17)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P,. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92 (Pubitemid 46359643)
2. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75 (Pubitemid 32120143)
3. Madersbacher S, Hochreiter W, Burkhard F, et al,. Radical cystectomy for bladder cancer today -a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 21: 690-6 (Pubitemid 46621904)
4. Tilki D, Svatek RS, Novara G, et al,. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol 2010; 184: 888-94
5. Thrasher JB, Frazier HA, Robertson JE, Paulson DF,. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? J Urol 1994; 152: 393-6
6. Mallén Mateo E, Gil Martínez P, Gil Sanz MJ, Sancho Serrano C, Pascual Regueriro D, Rioja Sanz LA,. [Stage pT0 bladder tumors after radical cystectomy: a review of our series]. Actas Urol Esp 2006; 30: 763-71 (Pubitemid 44869519)
7. Cho KS, Seo JW, Park SY, et al,. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy. Urol Int 2008; 81: 394-8
8. Loizaga Iriarte A, Senarriaga Ruiz de la Illa N, Lacasa Viscasillas I, Rábade Ferreiro A, Iriarte Soldevilla I, Unda Urzaiz M,. [Does a pT0 cystectomy specimen imply being tumour-free in the long term?] Actas Urol Esp 2009; 33: 865-8
9. Hitier M, Marconnet L, Luyckx F, et al. [Predictive factors and long term carcinogenic results of patients who no longer have residual tumors (stage pT0) on specimens of total cystectomy carried out for cancer of the bladder. Prog Urol 2010; 20: 130-7
10. Volkmer BG, Kuefer R, Bartsch G Jr, et al,. Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 2005; 104: 2384-91 (Pubitemid 41691559)
11. Palapattu GS, Shariat SF, Karakiewicz PI, et al,. Bladder Cancer Research Consortium. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol 2006; 175: 1645-9
12. Wittekind C, Meyer HJ, Bootz F, (Hrsg.). UICC: TNM Klassifikation Maligner Tumoren. 6. Auflage. Berlin, Heidelberg, New York: Springer, 2002
13. Sonpavde G, Goldman BH, Speights VO, et al,. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy. Cancer 2009; 115: 4104-9
14. Grossman HB, Natale RB, Tangen CM, et al,. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-66 (Pubitemid 37025405)
15. International Bladder Cancer Nomogram Consortium, Bochner BH, Kattan MW, Vora KC,. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006; 24: 3967-72 (Pubitemid 46630745)
16. Huddart RA, Hall E, Lewis R, Birtle A, SPARE Trial Management Group. Life and death of SPARE (selective bladder preservation against radical excision): reflections on why the SPARE trial closed. BJU Int 2010; 106: 753-5
17. Herr HW, Sogani PC,. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 2001; 166: 1296-9 (Pubitemid 32862159)